Emerald Advisers LLC Boosts Stake in Billiontoone, Inc. $BLLN

Emerald Advisers LLC boosted its position in shares of Billiontoone, Inc. (NASDAQ:BLLN) by 26.8% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 239,562 shares of the company’s stock after buying an additional 50,613 shares during the period. Emerald Advisers LLC’s holdings in Billiontoone were worth $18,911,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Rossby Financial LCC bought a new stake in Billiontoone in the 4th quarter worth approximately $25,000. Wells Fargo & Company MN purchased a new stake in shares of Billiontoone during the 4th quarter worth approximately $76,000. Smartleaf Asset Management LLC bought a new position in shares of Billiontoone during the 4th quarter valued at approximately $80,000. Nano Cap New Millennium Growth Fund L P bought a new position in shares of Billiontoone during the 4th quarter valued at approximately $82,000. Finally, Renaissance Capital LLC purchased a new position in shares of Billiontoone in the fourth quarter valued at $201,000.

Insiders Place Their Bets

In related news, CEO Oguzhan Atay sold 12,500 shares of Billiontoone stock in a transaction dated Thursday, July 9th. The shares were sold at an average price of $126.10, for a total transaction of $1,576,250.00. Following the completion of the transaction, the chief executive officer directly owned 12,500 shares of the company’s stock, valued at approximately $1,576,250. The trade was a 50.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Bosch John Roderick Ten sold 1,416 shares of the company’s stock in a transaction dated Monday, June 29th. The shares were sold at an average price of $120.00, for a total transaction of $169,920.00. Following the transaction, the senior vice president owned 33,552 shares in the company, valued at $4,026,240. The trade was a 4.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 153,049 shares of company stock valued at $16,768,021.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. JPMorgan Chase & Co. boosted their price target on shares of Billiontoone from $120.00 to $125.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Weiss Ratings upgraded shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, June 23rd. BTIG Research dropped their price objective on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating for the company in a research note on Thursday, May 7th. Finally, Guggenheim started coverage on shares of Billiontoone in a report on Monday, June 29th. They issued a “buy” rating and a $125.00 target price on the stock. Six investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $126.00.

Billiontoone Stock Performance

NASDAQ:BLLN opened at $123.25 on Tuesday. The stock’s fifty day moving average is $101.46 and its 200 day moving average is $89.09. Billiontoone, Inc. has a fifty-two week low of $61.96 and a fifty-two week high of $138.70. The firm has a market capitalization of $5.67 billion and a PE ratio of 224.09. The company has a debt-to-equity ratio of 0.18, a quick ratio of 10.58 and a current ratio of 10.92.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.01 by $0.33. The company had revenue of $108.39 million during the quarter, compared to the consensus estimate of $95.81 million. The firm’s quarterly revenue was up 83.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.39) earnings per share. On average, sell-side analysts anticipate that Billiontoone, Inc. will post 0.93 earnings per share for the current year.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.